Page last updated: 2024-11-01

omeprazole and Dermatomyositis, Adult Type

omeprazole has been researched along with Dermatomyositis, Adult Type in 2 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pan, Y1
Chong, AH1
Williams, RA1
Green, J1
Sinclair, R1
Caramaschi, P1
Blasi, D1
Carletto, A1
Randon, M1
Bambara, LM1

Other Studies

2 other studies available for omeprazole and Dermatomyositis, Adult Type

ArticleYear
Omeprazole-induced dermatomyositis.
    The British journal of dermatology, 2006, Volume: 154, Issue:3

    Topics: Aged, 80 and over; Anti-Ulcer Agents; Dermatomyositis; Drug Eruptions; Female; Humans; Omeprazole

2006
Megaoesophagus in a patient affected by dermatomyositis.
    Clinical rheumatology, 1997, Volume: 16, Issue:1

    Topics: Anti-Ulcer Agents; Dermatomyositis; Diagnosis, Differential; Esophageal Achalasia; Esophagoscopy; Fe

1997